Cosmos Pharmaceutical Stock

Cosmos Pharmaceutical Liabilities 2024

Cosmos Pharmaceutical Liabilities

245.1 B JPY

Ticker

3349.T

ISIN

JP3298400007

In 2024, Cosmos Pharmaceutical's total liabilities amounted to 245.1 B JPY, a 42.05% difference from the 172.55 B JPY total liabilities in the previous year.

Cosmos Pharmaceutical Aktienanalyse

What does Cosmos Pharmaceutical do?

Cosmos Pharmaceuticals Corp is a Taiwanese company that was founded in 1984. The company specializes in the manufacturing and selling of pharmaceutical and health products, focusing on the needs of patients and healthcare providers. Cosmos Pharmaceuticals Corp has developed a strong business model over the years based on high-quality products, efficient production, and a strong distribution network. The company aims to offer a wide range of products and services to meet customers' needs. It is divided into three main business segments: manufacturing and marketing of drugs, manufacturing and selling of dietary supplements, and sales of medical devices. In the pharmaceutical manufacturing sector, Cosmos Pharmaceuticals Corp offers various drugs, including generics and innovative products that can be used for various conditions such as hypertension, diabetes, and obesity. The company also operates a specialized research center where new active ingredients and therapies are developed. In the dietary supplement sector, Cosmos Pharmaceuticals Corp is known for its products supporting cardiovascular health, immune function, and supplements for the maintenance of hair and skin health. The medical devices division of Cosmos Pharmaceuticals Corp offers a wide range of medical and diagnostic devices, including blood glucose meters, blood pressure monitors, and other devices used by patients and healthcare providers in hospitals and clinics. Furthermore, Cosmos Pharmaceuticals Corp has been committed to quality and customer satisfaction from the beginning. The company has implemented strict quality control standards and a comprehensive quality control system to ensure that all products and services meet the highest standards. The company also has an extensive customer service department that ensures prompt and effective handling of customer inquiries and complaints. Due to its focus on quality products, efficient production, and a strong distribution network, Cosmos Pharmaceuticals Corp has built an excellent reputation over the years. The company has managed to strengthen its presence in Asia and Europe and expand its product range. Cosmos Pharmaceuticals Corp has also established itself as a leading provider of generic and innovative products in Southeast Asia. In summary, Cosmos Pharmaceuticals Corp is a successful and forward-thinking company that strives to meet the needs of its customers and offers a wide range of products and services. With its strong position in the pharmaceutical, dietary supplement, and medical device industries, Cosmos Pharmaceuticals Corp is a company that will continue to grow in the future. Cosmos Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Cosmos Pharmaceutical's Liabilities

Cosmos Pharmaceutical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cosmos Pharmaceutical's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Cosmos Pharmaceutical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Cosmos Pharmaceutical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Cosmos Pharmaceutical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Cosmos Pharmaceutical stock

What is the level of liabilities of Cosmos Pharmaceutical this year?

Cosmos Pharmaceutical has a debt balance of 245.1 B JPY this year.

What were the liabilities of Cosmos Pharmaceutical compared to the previous year?

The liabilities of Cosmos Pharmaceutical have increased by 42.05% increased compared to the previous year.

What are the consequences of high debt for investors of Cosmos Pharmaceutical?

High liabilities can pose a risk for investors of Cosmos Pharmaceutical, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Cosmos Pharmaceutical?

Low liabilities mean that Cosmos Pharmaceutical has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Cosmos Pharmaceutical affect the company?

An increase in liabilities of Cosmos Pharmaceutical can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Cosmos Pharmaceutical affect the company?

A decrease in the liabilities of Cosmos Pharmaceutical can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Cosmos Pharmaceutical?

Some factors that can influence the liabilities of Cosmos Pharmaceutical include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Cosmos Pharmaceutical so important for investors?

The liabilities of Cosmos Pharmaceutical are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Cosmos Pharmaceutical take to modify the liabilities?

To change its liabilities, Cosmos Pharmaceutical can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Cosmos Pharmaceutical pay?

Over the past 12 months, Cosmos Pharmaceutical paid a dividend of 92.5 JPY . This corresponds to a dividend yield of about 1.22 %. For the coming 12 months, Cosmos Pharmaceutical is expected to pay a dividend of 101.34 JPY.

What is the dividend yield of Cosmos Pharmaceutical?

The current dividend yield of Cosmos Pharmaceutical is 1.22 %.

When does Cosmos Pharmaceutical pay dividends?

Cosmos Pharmaceutical pays a quarterly dividend. This is distributed in the months of December, June, December, June.

How secure is the dividend of Cosmos Pharmaceutical?

Cosmos Pharmaceutical paid dividends every year for the past 23 years.

What is the dividend of Cosmos Pharmaceutical?

For the upcoming 12 months, dividends amounting to 101.34 JPY are expected. This corresponds to a dividend yield of 1.34 %.

In which sector is Cosmos Pharmaceutical located?

Cosmos Pharmaceutical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Cosmos Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cosmos Pharmaceutical from 2/1/2025 amounting to 32.5 JPY, you needed to have the stock in your portfolio before the ex-date on 11/28/2024.

When did Cosmos Pharmaceutical pay the last dividend?

The last dividend was paid out on 2/1/2025.

What was the dividend of Cosmos Pharmaceutical in the year 2023?

In the year 2023, Cosmos Pharmaceutical distributed 117.5 JPY as dividends.

In which currency does Cosmos Pharmaceutical pay out the dividend?

The dividends of Cosmos Pharmaceutical are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cosmos Pharmaceutical

Our stock analysis for Cosmos Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmos Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.